We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Faramarz Ismail-Beigi

Faramarz Ismail-Beigi MD, PhD

Professor of Medicine, Physiology and Biophysics, and Biochemistry, Case Western Reserve University, Cleveland, Ohio

Dr. Ismail-Beigi was born in Tehran, Iran in 1941. He obtained his MD degree from Johns Hopkins University in 1968 and continued to do his residency in Internal Medicine there. He obtained a PhD in Biophysics in 1972 from University of California (San Francisco and Berkeley). From 1972 to 1982, he was professor and Chairman of Medicine at Shiraz University in Iran. He spent 10 years (1984-1993) as Professor of Medicine at Columbia University in New York before becoming Chief of Endocrinology at Case Western Reserve University in Cleveland, Ohio (1993-2009). He currently serves as a Professor of Medicine, Physiology, and Biochemistry at Case.

His interests are in teaching and in clinical and basic research in type 2 diabetes, glucose transporter biology, and insulin action. He was the Principal Investigator of the BARI2D trial, the ACCORD trial for the Ohio/Michigan Network, and is the PI of the ongoing NIH-funded GRADE trial in Cleveland (all focused on Type 2 Diabetes). Finally, over the past 15 years, he is conducting research projects on novel insulin formulations with improved action profiles; these projects are funded by the NIH, Helmsley Foundation, and Juvenile Diabetes Research Foundation. 

Disclosures

Dr. Ismail-Beigi has no relevant disclosures.